112
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The Development of a New Questionnaire to Measure the Burden of Immunoglobulin Treatment in Patients with Primary Immunodeficiencies: The IgBoT-35

, ORCID Icon, , , , , & ORCID Icon show all
Pages 1567-1584 | Published online: 03 Sep 2020

References

  • Sav A, Kendall E, McMillan SS, et al. ‘You say treatment, I say hard work’: treatment burden among people with chronic illness and their carers in Australia. Health Soc Care Community. 2013;21(6):665–674. doi:10.1111/hsc.12052
  • May CR, Eton DT, Boehmer K, et al. Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014;14(1):1–11. doi:10.1186/1472-6963-14-281
  • Mair FS, May CR. Thinking about the burden of treatment. BMJ. 2014;349:g6680. doi:10.1136/bmj.g6680
  • Tran VT, Montori VM, Eton DT, Baruch D, Falissard B, Ravaud P. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med. 2012;10(1):68. doi:10.1186/1741-7015-10-68
  • Brod M, Hammer M, Christensen T, Lessard S, Bushnell DM. Understanding and assessing the impact of treatment in diabetes: the treatment-related impact measures for diabetes and devices (TRIM-diabetes and TRIM-diabetes device). Health Qual Life Outcomes. 2009;7:83. doi:10.1186/1477-7525-7-83
  • Pifferi M, Bush A, Di Cicco M, et al. Health-related quality of life and unmet needs in patients with primary ciliary dyskinesia. Eur Respir J. 2010;35(4):787–794. doi:10.1183/09031936.00051509
  • Chinn IK, Orange JS. Immunodeficiency disorders. Pediatr Rev. 2019;40(5):229LP- 242. doi:10.1542/pir.2017-0308
  • Espanol T, Prevot J, Drabwell J, Sondhi S, Olding L. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Prefer Adherence. 2014;8:621–629. doi:10.2147/PPA.S60771
  • Gardulf A, Nicolay U. Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies. Curr Opin Allergy Clin Immunol. 2006;6(6):434–442. doi:10.1097/01.all.0000246619.49494.41
  • Mozaffari H, Pourpak Z, Pourseyed S, Moin M, Farhoodi A. Health-related quality of life in primary immune deficient patients. Iran J Allergy Asthma Immunol. 2006;5:23–27.
  • Jones GL, Vogt KS, Chambers D, Clowes M, Shrimpton A. What is the burden of immunoglobulin replacement therapy in adult patients with primary immunodeficiencies? A systematic review. Front Immunol. 2018;9(JUL). doi:10.3389/fimmu.2018.01308
  • Daly PB, Evans JH, Kobayashi RH, et al. Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions. Ann Allergy. 1991;67(5):504–510.
  • Nicolay U, Haag S, Eichmann F, Herget S, Spruck D, Gardulf A, Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapy. Qual Life Res. 2005;14(7):1683–1691. doi:10.1007/s11136-005-1746-x
  • Gardulf A, Nicolay U, Math D, et al. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol. 2004;114(4):936–942. doi:10.1016/j.jaci.2004.06.053
  • Vultaggio A, Azzari C, Milito C, et al. Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study. Clin Drug Investig. 2015;35(3):179–185. doi:10.1007/s40261-015-0270-1
  • Gardulf A, Borte M, Ochs HD, Nicolay U. Vivaglobin clinical study group. Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy. Clin Immunol. 2008;126(1):81–88. doi:10.1016/j.clim.2007.06.009
  • Beauté J, Levy P, Millet V, et al. Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies. Clin Exp Immunol. 2009;160(2):240–245. doi:10.1111/j.1365-2249.2009.04079.x
  • Jones CA, Rojavin M, Baggish JS. Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety. J Pharm Heal Serv Res. 2012;3(1):41–47. doi:10.1111/j.1759-8893.2011.00076.x
  • US Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist. 2009;74(235):65132–65133.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. doi:10.1191/1478088706qp063oa
  • Moores KL, Jones GL, Radley SC. Development of an instrument to measure face validity, feasibility and utility of patient questionnaire use during health care: the QQ-10. Int J Qual Heal Care. 2012;24(5):517–524. doi:10.1093/intqhc/mzs051
  • Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Heal J Int Soc Pharmacoeconomics Outcomes Res. 2005;8(2):94–104. doi:10.1111/j.1524-4733.2005.04054.x
  • Field AP. Discovering Statistics Using SPSS: (And Sex, Drugs and Rock’n’roll). SAGE; 2005. Available from: https://books.google.co.uk/books?id=IY61Ddqnm6IC. Accessed June 232020.
  • Kline P. A Handbook of Test Construction: Introduction to Psychometric Design. New York, NY, US: Methuen; 1986.
  • Kaiser HF, Rice J. Little Jiffy, Mark Iv. Educ Psychol Meas. 1974;34(1):111–117. doi:10.1177/001316447403400115
  • Stevens J. Applied Multivariate Statistics for the Social Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1992.
  • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334. doi:10.1007/BF02310555
  • Helmstadter GC. Principles of Psychological Measurement. Appleton-Century-Crofts; 1964. Available from: https://books.google.co.uk/books?id=khHs5Zhz4JcC. Accessed June 232020.
  • Carmines E, Zeller R. Reliability and Validity Assessment. 2455 Teller Road, Thousand Oaks California 91320 United States of America: SAGE Publications, Inc; 1979. doi:10.4135/9781412985642
  • Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. Oxford University Press; 1995. Available from: https://books.google.co.uk/books?id=8TYQAQAAMAAJ. Accessed June 232020.
  • Nunnally JC. Psychometric Theory. McGraw-Hill; 1978. Available from: https://books.google.co.uk/books?id=WE59AAAAMAAJ. Accessed June 232020.
  • Lamping DL, Schroter S, Marquis P, Marrel A, Duprat-Lomon I, Sagnier -P-P. The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest. 2002;122(3):920–929. doi:10.1378/chest.122.3.920
  • Hajjar ST. Statistical analysis: internal-consistency reliability and construct validity. Int J Quant Qual Res Methods. 2018;6(1):27–38.
  • Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York, NY, US: McGraw-Hill, Inc; 1994.
  • Gandek B, Ware JE, Aaronson NK, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries. J Clin Epidemiol. 1998;51(11):1149–1158. doi:10.1016/S0895-4356(98)00106-1
  • Kline P. The Handbook of Psychological Testing. Routledge; 2000. Available from: https://books.google.co.uk/books?id=lm2RxaKaok8C. Accessed June 232020.
  • Clark LA, Watson D. Constructing validity: basic issues in objective scale development. Psychol Assess. 1995;7(3):309–319. doi:10.1037/1040-3590.7.3.309